store at low temperature
store at -20°C
Labetuzumab is a humanized anti-carcinoembryonic antigen (CEA) monoclonal antibody with anticancer activity that inhibits tumor growth and is used in the study of thyroid and colorectal cancer (CRC).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 80,000 |
2 mg | 在庫あり | ¥ 109,500 |
5 mg | 在庫あり | ¥ 159,500 |
10 mg | 在庫あり | ¥ 250,500 |
25 mg | 在庫あり | ¥ 381,000 |
50 mg | 在庫あり | ¥ 512,000 |
100 mg | 在庫あり | ¥ 677,000 |
説明 | Labetuzumab is a humanized anti-carcinoembryonic antigen (CEA) monoclonal antibody with anticancer activity that inhibits tumor growth and is used in the study of thyroid and colorectal cancer (CRC). |
In vivo | In vivo, Labetuzumab inhibits tumor growth following a single intravenous administration at a dose of 0.5 mg per rat [1]. |
別名 | IMMU-14, hMN-14, IMMU-100 |
分子量 | N/A |
CAS No. | 219649-07-7 |
store at low temperature
store at -20°C
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Labetuzumab 219649-07-7 IMMU-14 hMN-14 IMMU-100 Inhibitor inhibitor inhibit